We would love to hear your thoughts about our site and services, please take our survey here.
EQT fundamentals rated 10/10 with a strong buy recommendations
https://twitter.com/dr_tkd15/status/1465748794339954689?s=21
I would also like to note that Vlad & his team are somehow supervised/directed /or at least advised by HEMO chairman who is one of the world most Intelligent scientist in the field. He has made a real impact and significant changes to the commercial and medical aspects of the field, particularly in relation to Mechanism of Autoimmunity. Read below about him:
Biography (Chairman of Hemogenyx)
Professor Sir Marc Feldmann is a pre-eminent medically trained immunologist at the University of Oxford where he was Head of the Kennedy Institute of Rheumatology until 2014 and now Emeritus Professor. He trained in medicine at Melbourne University and then earned a Ph.D. in Immunology at the Walter & Eliza Hall Institute with Sir Gus Nossal, before working in London at the Imperial Cancer Research Fund. Sir Feldmann’s main research interests are immunoregulation, understanding mechanisms of autoimmunity and the role of cytokines in disease, and working out how to fill unmet medical needs
His work in London led to the generation of a new hypothesis for the mechanism of autoimmunity, linking upregulated antigen presentation and cytokine expression. Testing this hypothesis led to the discovery, with colleague Sir Ravinder Maini, of the pivotal role of TNFa (Tumor Necrosis Factor alpha) in the pathogenesis of rheumatoid arthritis. This major discovery has therapy not only of rheumatoid arthritis but other chronic inflammatory diseases (eg Inflammatory bowel disease, psoriasis, ankylosing spondylitis), and helped change the perception of monoclonal antibodies from niche products to mainstream therapeutics. Anti-TNF therapeutics are the current leading drug class with 2016 sales exceeding $36 Billion.
This has led to much scientific recognition, for example election to the Royal Society and Academy of Medical Sciences in London, the National Academy of Sciences USA and the Australian Academy of Science, and multiple major International prizes: including the Crafoord Prize of the Royal Swedish Academy of Sciences, the Albert Lasker Clinical Research Award (NY), the Ernst Schering Prize , the Paul Janssen Award for Biomedical Research and the Canada-Gairdner Award. He was also the first recipient in biology or medicine of the EU/ European Patent Inventor of the Year Award in the Lifetime Achievement category. In addition, Sir Marc has advised more than 20 of the largest pharmaceutical and biotech companies in the world and has mentored some of the most successful scientists, many of whom have become senior figures in the commercial pharmaceutical world. Sir Marc was knighted in the 2010 Queen’s Birthday and was in Australia with the knighthood equivalent, the Companion of the Order of Australia.
Other senior and junior team members had also excellent experiences in elite medical and biology schools such as Cornell etc
In conclusion: we have one of the word best and most trusted teams to take this company forward. This only needs “patience”. Good lu
https://twitter.com/vmsandler/status/1405654103464812555?s=21
Washington is beautiful and clean again and Maryland to my surprise is a biotech powerhouse. It is such a delight to finally talk to real people rather than talking heads. Body language matters! Good to See real labs and production facilities, learn how things are done elsewhere
All those who compare with Hemo are just ignorants and enemies of themselves -otherwise they have their own agendas. I have been invested in Hemo since long time ago and iam very positive about it. However, most of shareholders know that Hemo CEO is to be blamed for what happened. Although he is a bright fantastic scientist, but he is stupid (if I may) when it comes to conducting business and he keeps doing mistakes over and over. We begged him to hire a business-oriented CEO and he just focus on the medical aspects of the company but he never welcomed such a proposition. The deal broke as a result of failed negotiations between the two parties and the greed from funders. Also when the deal was announced it has no clear picture or any good details comparing to what we have seen today. SYME today proposes a well thought and detailed RNS which you could feel that both parties are happy working this way and both look forward to an excellent success story. It also seems that Negma has already seen something more than what we all know. Another issue is that we we pick up Hemo and forget the too many successful stories of other companies who have used the same approach. Again, this sadly presents disgusting agendas from many people who know and read nothing other than rubbish tweets and only headlines with getting into the depth of the stories. Guess what, I am not here to convince anyone, but sooner or later Syme will steel the show and they will be soon bombarding you with a flow of excellent news in relation to Securitisation, Middle East, US , Europe, UK and anything good that you would like to hear about. Be positive and confident and don’t waste your time plz.
Oh and finally, please have a look and see a sample of those businesses who have been funded by Negma and do business with them and u will have the best sleep ever. Until later…….
Completely agree. Been topping up every week or so at these prices. For example, today I bought 49k shares just before market closes and it is reported as sell!!!
14-Jun-21 16:27:57 1.47 49,000 Sell* 720.30 O
The above transaction is mine which is a “Buy” but it shows as sell.
I love the idea that for one of the product they are seeing some positive data and they just want to make sure that these data are Reproducible and repeatable- this is absolutely significant piece of news in today’s interview, good luck guys, future is bright
https://twitter.com/dr_tkd15/status/1381332119771828232?s=21
Although power horse energy is much trending and popular among investors, but looking at those stats, EQT would look significantly undervalued - I see 5p coming sooner than what we would expect. Good long LTH
Relax everyone. This will come and will do nicely. This board is shambolic with immature comments and investors. I really hope they even release it after trading hours, as this would be the biggest disappointment for those who are eagerly waiting to manipulate SP— congrats for what is coming LTH!!
With all respect to u Calamari and Mick, but I disagree with you. Well, yes everything start as a theory, so what!!! It’s a new born business so what do you expect, to start with billions of dollars in their account to make you both pleased. The team at Syme works really hard to build something especial. And the issues they are working on are even academically known to be the most complicated to be processed and completed. For god sake, they had their IPO last year. Give it a rest mate. So yeah it’s a theory which will soon turn into an excellent practice so you can both learn a good lesson in life. Even your parent when thought to bring you to this life, it was a theory and just a talk but sadly they turn you into this ugly useless practice. Amazon, Apple, Tesla, have all been built based on excellent theoretical strands, and now they are an example of best practice. Even if AZ wants more and more time and want to expand this theory we will still wait because what is coming is bigger than anything you could ever imagine. Mark my words and mark my post as I will remind you one day with what will Syme become. Whether you like it or not, they will become a force in the industry. Save your time and go do something useful to yourselves plz.
A summary of what to expect in the next reading update:
1. Inventory Funding Programme
A- Open Funding: this is managed by StormHarbour Securities. Its in the final phase, as majority of issuance processes completed to deliver the first transaction and create an entirely new Inventory Monetisation asset. It’s repeatable and scalable. We expect a positive update on this one such as the detail of the securitisation transaction and Inventory funding partner etc...otherwise to be confirmed late April.
B- Captive Bank: SYME to be the main beneficiary of the acquisition of the European Bank which will provide funding through the Platform, via a novel "banking as a service" model. SYME aims to complete this during the first quarter of 2021, hence we expect another major positive update for this one.
C- Self-Funding: We also expect an update on two Italian Financial Institutions (collaborating with the captive Bank) to conduct self-funding transactions. They also working on insurance product.
2. Update on Client Company Origination
This has been significantly growing (last update was (value of €1.9bn with 152 companies). We expect a very significant progress on these number/value, particularly from the EPIC platform. I expect the number to be updated to almost the double across all the sectors.
3. Update on Geographies:
UK: To be the key hub for its Inventory Monetisation service as well as a "pivot" for cross-border monetisation operations. We expect updates on Syme agreements with SIA and ALTIMAPA. We also expect updates on the “global asset manager” for an Inventory funding facility with a potential value up to €500m (this is for Uk companies).
UAE: having been authorised to offer Shariah-compliant service, we now expect updates in relation to their local partner iMass,and notably a potential involvement with government parties to offer Inventory Monetisation process to some of their sector holding companies as an add-on to their existing digital warehouse solutions.
US: updates are also expected here in relation to the agreement signed with AB/TA and on delivering an innovative inventory "in transit" monetisation model. TA claimed that they are 114 asset-based lending operators in the US with an inventory finance market worth more than US$1trn.
One final important point, given that SYME (wit their auditors) have finally completed the development of IFRS relating to the multi-jurisdictional themes of Inventory Monetisation, this will much help in progressing on every aspect outlined above, and support the expansion of SYME internationally. Good luck to all.
https://twitter.com/dr_tkd15/status/1376159123348336642?s=21
Yes just saw that: https://twitter.com/dr_tkd15/status/1374103897543958531?s=21
Never been excited as for this brilliant company. It’s the best future investment for me. I hope to go above 5p after In April when new figures announced. Good luck to all LTH
This very much could be what #Syme will acquire. TF successfully invested in more than US$500mn of physical commodity trade through 700+ transactions across 15+ countries and 25+ commodity types, with more than 800 SME counterpart entities KYC reviewed.
https://twitter.com/dr_tkd15/status/1372246514513371139?s=21
A good read with rather a balanced perspective
https://twitter.com/dr_tkd15/status/1371864993336078343?s=21